KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Non-cash Items (2016 - 2019)

Supernus Pharmaceuticals (SUPN) has disclosed Non-cash Items for 9 consecutive years, with $2.6 million as the latest value for Q1 2019.

  • On a quarterly basis, Non-cash Items rose 7.07% to $2.6 million in Q1 2019 year-over-year; TTM through Mar 2019 was $2.6 million, a 7.07% increase, with the full-year FY2018 number at $57.2 million, up 2830.2% from a year prior.
  • Non-cash Items was $2.6 million for Q1 2019 at Supernus Pharmaceuticals, up from $1.9 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $108.5 million in Q4 2017 to a low of $856008.0 in Q2 2015.
  • A 5-year average of $11.8 million and a median of $1.9 million in 2018 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: soared 530.0% in 2015, then tumbled 98.26% in 2018.
  • Supernus Pharmaceuticals' Non-cash Items stood at $12.6 million in 2015, then soared by 333.91% to $54.7 million in 2016, then surged by 98.49% to $108.5 million in 2017, then crashed by 98.26% to $1.9 million in 2018, then surged by 37.87% to $2.6 million in 2019.
  • Per Business Quant, the three most recent readings for SUPN's Non-cash Items are $2.6 million (Q1 2019), $1.9 million (Q4 2018), and $1.9 million (Q3 2018).